首页>
外国专利>
BIOMARKER FOR PREDICTING THERAPEUTIC EFFICACY OF ALLERGEN IMMUNOTHERAPY
BIOMARKER FOR PREDICTING THERAPEUTIC EFFICACY OF ALLERGEN IMMUNOTHERAPY
展开▼
机译:预测过敏原免疫疗法治疗功效的生物标志物
展开▼
页面导航
摘要
著录项
相似文献
摘要
[Problem] To provide a biomarker for predicting the therapeutic efficacy of allergen immunotherapy.;[Means for solving the problem] A method for detecting the efficacy of allergen immunotherapy, the method comprising the steps of: detecting a copy number variation of at least one gene selected from the gene group, AGXT2L2, AZGP1, CAV3, CEP72, CUL4A, CXCR7, C12orf60, C16orf48, C19orf34, DNAJB8, FTH1, GEMIN4, GIGYF2, GJC3, HTT, ITCH, MARK2, METT10D, NAV3, NOB1, PAFAH2, PLEKHG4B, PPFIA1, SCARNA11, SDF2L1, SMPD3, SNORA44, SRP14, ST6GALNAC1, SULF2, TMED6, TYRP1, WFDC13, ZNFX1, NCAM2, PCDH17, CHODL, BTG3, DIAPH3, GBA3, IFRD1, KCNT2, THOC7, TMEM168, BST1, C7orf53, CD38, DCUN1D1, FGFBP1, FOXP2, GLRB, GTF2B, HSP90AB2P, MCCC1, MDFIC, ODF2L, PDGFC, SEP15, SH3GLB1, TDRD3, YEATS2, CCDC127, C14orf180, SIVA1, TNFRSF14, AHNAK2, C14orf79, LOC25845, PLD4, GPR132, LOC389257, BRF1 and ADSSL1, from a specimen to be examined collected from the subject; and correlating the obtained result from detecting the copy number variation with effectiveness of the allergen immunotherapy.
展开▼